Noah Fromson
Public Relations Representative
Fromson joined Michigan Medicine in March 2021. He covers the neurosciences and cardiovascular medicine. He spent three years as a television reporter in West Michigan and is passionate about multimedia storytelling. Contact: [email protected] Twitter: @noahfromson
Health Lab
For psoriasis, molecular signature in healthy-appearing skin may be best predictor of response to anti-TNF treatment
Patients with psoriasis may hold clues in their genetic profile to predicting anti-TNF treatment response, furthering the application of precision medicine.
Health Lab
Patients with rare scleroderma have deadlier organ damage, despite getting standard treatment
Researchers say it’s a sign that more targeted therapies are needed for the vulnerable patient population.
Health Lab
Resident stories: Challenges and lessons learned caring for diverse, vulnerable populations in the ER
Centering health equity and culturally competent care are essential steps to fixing health disparities and dismantling systemic racism within the health care system. A new paper featuring emergency department resident stories shines a light on where gap.
Health Lab
Pediatric injury prevention online course looks to address substantial gap in training
Injury prevention for kids and teens has only become more important during the COVID-19 pandemic. A free online course from experts has made this crucial information more accessible.
Health Lab
Long wait at the emergency room? What to consider before heading in
Emergency rooms across the country are stressed with COVID-19 and other patients. Follow this expert guide for other options for accessing health care rapidly when you need it.
Health Lab
Common anti-seizure medication associated with elevated fracture risk in kids with epilepsy
The findings will help physicians determine treatment options for children and young teens.
Health Lab
COVID-19 antibodies persist, reduce reinfection risk for up to six months, study finds
The antibodies ability to neutralize COVID-19 did not differ significantly over the six-month period.
Health Lab
Balance between sleep and exercise may be key to help osteoarthritis patients manage pain
Although osteoarthritis has no cure, researchers are developing a new intervention to improve patients’ chronic pain outcomes.
Health Lab
Paralyzed from a crash, man saved by hip surgery after life-threatening infection
He couldn’t feel the wounds open on his sides. Without surgery he would be permanently bed-bound.
Health Lab
‘You can do anything’: teen with disabilities reaches for her dreams
Born with cerebral palsy and brachial plexus palsy, Shianna Wilson has been working with Michigan Medicine doctors to push boundaries and change the narrative around what life is like for people living with disabilities.
Health Lab
Studying an extra COVID-19 vaccine dose in people with autoimmune diseases
How would a third dose of COVID vaccine affect people with autoimmune disease? A new NIH study co-led by a U-M rheumatologist aims to find out.
Health Lab
Complexities of foot and ankle surgery: finding the right solutions
Foot and ankle conditions are as varied as the patients living with them. A U-M orthopaedic surgeon advocates personalized medicine to meet these unique needs.
News Release
Michigan Medicine to help lead NIH study of extra COVID-19 vaccine dose in people with autoimmune disease
A Michigan Medicine physician will co-lead a National Institutes of Health study(link is external) of antibody response to an additional dose of the COVID-19 vaccine in people with autoimmune diseases who did not present a strong immune response to the first round of authorized vaccination.
Health Lab
Symptoms, like pain and fatigue, often cluster in newly diagnosed MS
Anxiety, depression, pain and fatigue often happen at the same time for patients newly diagnosed with multiple sclerosis (MS).
News Release
Treating newly infected COVID-19 patients with plasma from COVID survivors demonstrates no significant benefit, study finds
A new study published by the National Institutes of Health found that COVID-19 convalescent plasma did not prevent disease progression in an at-risk group of COVID patients when administered within one week of their symptoms.
